Business News • MarketWire • Sunshine Biopharma Acquires All Remaining Worldwide Patents for Its Adva-27a Anticancer Compound |
Sunshine Biopharma Acquires All Remaining Worldwide Patents for Its Adva-27a Anticancer Compound |
|
|
Sunshine Biopharma Acquires All Remaining Worldwide Patents for Its Adva-27a Anticancer Compound
MONTREAL, QC--(Marketwired - Dec 28, 2015) - Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, announced today that it has acquired all of the remaining rights, title and interest in and to all worldwide patents for the Company's Adva-27a anticancer compound. The Patent Purchase Agreement executed today provides Sunshine with direct ownership of all issued and pending Adva-27a related patents, which include all rights to this intellectual property worldwide. Prior, Sunshine had ownership of only the U.S. patent.
View More : http://www.marketwired.com/mw/release.do?id=2084641&sourceType=3
|
|
|